NCT06303739View on ClinicalTrials.gov

Psilocybin-Assisted Therapy in Treatment-Resistant Depression

PHASE3RecruitingINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

April 19, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
Refractory DepressionTreatment Resistant Depression
Interventions
DRUG

psilocybin

25mg of psilocybin administered during treatment session, accompanied by preparation before, integration after, and assistive therapy during the session.

Trial Locations (1)

27514

RECRUITING

UNC Chapel Hill Medical Center, Chapel Hill

All Listed Sponsors
collaborator

Foundation of Hope, North Carolina

OTHER

lead

University of North Carolina, Chapel Hill

OTHER